Revvity, Inc. RVTY
i
Market dataready · fetched 2026-11-12T02:15:25.807Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T00:00:00.001789631Z
FundamentalsSEC EDGAR · ready · as of 2026-10-04 · fetched 2026-11-12T02:15:25.399377+00:00
Revvity, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 173.90 | 66.6% | 11.0% | 146.31 | 63.2% | 8.7% |
| 25Δ | 169.68 | 60.6% | 8.6% | 148.86 | 62.6% | 7.5% |
| 30Δ | 167.57 | 62.1% | 7.7% | 151.17 | 61.6% | 6.4% |
| 35Δ | 165.46 | 63.6% | 6.8% | 153.30 | 60.4% | 5.5% |
| 40Δ | 163.42 | 65.7% | 6.1% | 155.37 | 59.1% | 4.6% |
| 45Δ | 161.41 | 67.9% | 5.4% | 157.18 | 58.0% | 4.0% |
| 50Δ | 159.33 | 70.1% | 4.8% | 159.00 | 57.0% | 3.3% |
| 55Δ | 157.09 | 72.2% | 4.2% | 160.74 | 55.6% | 2.8% |
| 60Δ | 154.83 | 74.3% | 3.7% | 162.39 | 54.0% | 2.3% |
| 65Δ | 152.39 | 74.7% | 3.1% | 164.04 | 52.4% | 1.8% |
| 70Δ | 149.91 | 75.3% | 2.5% | 165.84 | 51.2% | 1.4% |
| 75Δ | 146.02 | 84.4% | 2.2% | 167.84 | 50.8% | 1.1% |
| 80Δ | 142.05 | 89.2% | 1.8% | 169.85 | 50.3% | 0.8% |
20Δ
- Pseudo strike
- 173.90
- IV
- 66.6%
- B/E move
- 11.0%
- Pseudo strike
- 146.31
- IV
- 63.2%
- B/E move
- 8.7%
25Δ
- Pseudo strike
- 169.68
- IV
- 60.6%
- B/E move
- 8.6%
- Pseudo strike
- 148.86
- IV
- 62.6%
- B/E move
- 7.5%
30Δ
- Pseudo strike
- 167.57
- IV
- 62.1%
- B/E move
- 7.7%
- Pseudo strike
- 151.17
- IV
- 61.6%
- B/E move
- 6.4%
35Δ
- Pseudo strike
- 165.46
- IV
- 63.6%
- B/E move
- 6.8%
- Pseudo strike
- 153.30
- IV
- 60.4%
- B/E move
- 5.5%
40Δ
- Pseudo strike
- 163.42
- IV
- 65.7%
- B/E move
- 6.1%
- Pseudo strike
- 155.37
- IV
- 59.1%
- B/E move
- 4.6%
45Δ
- Pseudo strike
- 161.41
- IV
- 67.9%
- B/E move
- 5.4%
- Pseudo strike
- 157.18
- IV
- 58.0%
- B/E move
- 4.0%
50Δ
- Pseudo strike
- 159.33
- IV
- 70.1%
- B/E move
- 4.8%
- Pseudo strike
- 159.00
- IV
- 57.0%
- B/E move
- 3.3%
55Δ
- Pseudo strike
- 157.09
- IV
- 72.2%
- B/E move
- 4.2%
- Pseudo strike
- 160.74
- IV
- 55.6%
- B/E move
- 2.8%
60Δ
- Pseudo strike
- 154.83
- IV
- 74.3%
- B/E move
- 3.7%
- Pseudo strike
- 162.39
- IV
- 54.0%
- B/E move
- 2.3%
65Δ
- Pseudo strike
- 152.39
- IV
- 74.7%
- B/E move
- 3.1%
- Pseudo strike
- 164.04
- IV
- 52.4%
- B/E move
- 1.8%
70Δ
- Pseudo strike
- 149.91
- IV
- 75.3%
- B/E move
- 2.5%
- Pseudo strike
- 165.84
- IV
- 51.2%
- B/E move
- 1.4%
75Δ
- Pseudo strike
- 146.02
- IV
- 84.4%
- B/E move
- 2.2%
- Pseudo strike
- 167.84
- IV
- 50.8%
- B/E move
- 1.1%
80Δ
- Pseudo strike
- 142.05
- IV
- 89.2%
- B/E move
- 1.8%
- Pseudo strike
- 169.85
- IV
- 50.3%
- B/E move
- 0.8%
Options history
Table
| Date | IV (%) |
|---|---|
| 39.02% | |
| 38.61% | |
| 39.49% | |
| 41.69% | |
| 42.02% | |
| 38.45% | |
| 39.30% | |
| 38.79% | |
| 37.89% | |
| 37.07% | |
| 37.01% | |
| 36.51% | |
| 37.37% | |
| 36.38% | |
| 37.36% | |
| 37.07% | |
| 41.08% | |
| 42.41% | |
| 41.38% | |
| 40.39% | |
| 41.18% | |
| 45.96% | |
| 45.15% | |
| 39.24% | |
| 40.06% | |
| 39.93% | |
| 40.02% | |
| 40.29% | |
| 40.92% | |
| 43.44% | |
| 43.63% | |
| 44.62% | |
| 44.41% | |
| 44.05% | |
| 43.79% | |
| 47.06% | |
| 47.58% | |
| 47.16% | |
| 46.97% | |
| 49.72% | |
| 50.67% | |
| 51.16% | |
| 52.26% | |
| 47.66% | |
| 47.40% | |
| 46.96% | |
| 47.84% | |
| 47.93% | |
| 48.06% | |
| 48.24% | |
| 48.44% | |
| 48.09% | |
| 50.03% | |
| 50.57% |
Diagnostics & Research
SHC
Sotera Health Company provides sterilization, laboratory testing, and advisory services to the medical device, pharmaceutical, and food industries in the Americas, Europe, and…
More →TMO
Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other…
More →VCYT
Veracyte, Inc. is a genomic diagnostics company in the United States and internationally. The company is headquartered in South San Francisco, California.
More →WAT
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.
More →WGS
Sema4 Holdings Corp. The company is headquartered in Stamford, Connecticut.
More →XGN
Description unavailable
More →